Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results
Date:8/5/2008

and the first six months of 2008 due to the disruption to sales activities resulting from the restructuring of Endu's sales force. In addition, the Company has offered a greater than anticipated volume of Endu for free to existing and new patients to accelerate participation in Endu's Phase IV clinical studies, resulting in fewer products being sold at the regular price.

Also, revenue from Yidasheng for the second quarter and the first six months of 2008 was lower than expected as the Company did not proceed with the planned transition of Yidasheng from the agency-sales model to Bicun's sales model. Under Yidasheng's current agency-sales model, sales and marketing activities and corresponding expenses are the responsibility of the sales agents; accordingly, the sales agents are offered a lower price than under Bicun's sales model, in which Simcere is responsible for product sales and marketing. Because Simcere does not incur corresponding marketing and sales costs under Yidasheng's agency-sales model, Simcere's net profit for the quarter was not impacted by the lower than expected Yidasheng revenue.

Due to the reasons cited above, the Company has adjusted its targeted total revenue for the full year of 2008; targeted net income for the full year of 2008 has not changed.

2008 Second Quarter Financial Results

Total revenue for the second quarter of 2008 was RMB436.2 million (US$63.6 million), representing a growth of 30.4% from RMB334.5 million for the same period in 2007. For the first six months of 2008, total revenue was RMB830.8 million (US$121.1 million), representing an increase of 28.5% from RMB646.7 million for the same period in 2007.

Revenue from Endu, the Company's patented anti-cancer pharmaceutical launched in July 2006, totaled RMB63.1 million (US$9.2 million) in the second quarter of 2008, an increase of 4.6% compared to RMB60.3 million in the corresponding period in 2007. For the first six months of 2008, revenue fro
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
3. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
4. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
6. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
7. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
8. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
9. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... UT (PRWEB) September 23, 2014 Pricing ... addition of the following facilities. , 1. Prairie ... & Pain Institute is a nationally recognized leader in ... frequently presents both nationally and internationally on leading-edge, minimally ... experience using these techniques and quicker recovery times for ...
(Date:9/23/2014)... NC (PRWEB) September 23, 2014 Scarless ... open an 18,000 – square foot dermatology and vein ... a nationwide chain of dermatology centers. The center will ... training of healthcare professionals for the treatment of skin ... be led by Kamran Goudarzi, MD, a pioneer in ...
(Date:9/23/2014)... September 23, 2014 Recently, Best Cheap ... Bluehost and JustHost are the best VPS hosting suppliers ... make money from hosting, reseller hosting is a very ... allotted resources to host the others’ websites under his ... is very famous for two primary hosting plans (reseller ...
(Date:9/23/2014)... September 23, 2014 On September 9th, 2014, ... the most technically advanced horticultural LED grow light that they ... the XL750 and XL1000 , releasing a ... the experienced horticulturalist, because it has what the whole community ... Kind LED's grower-tested 12 band spectrum (also known as "the ...
(Date:9/23/2014)... September is Self-Improvement Month and the ... people improve their lives every day. This month long ... small to make improvements in their lives. The idea ... lives and make easy adjustments towards their goals. Whether ... or getting on track with finances, this month is ...
Breaking Medicine News(10 mins):Health News:PricingHealthcare.com Adds Pricing Data for Pittsburgh, New Orleans, Peoria Facilities 2Health News:Scarless VeinCare Partners with DemOne to Open State-of-the-Art Facility for Vein and Dermatology Care 2Health News:Scarless VeinCare Partners with DemOne to Open State-of-the-Art Facility for Vein and Dermatology Care 3Health News:Best Cheap Hosting USA: Bluehost And JustHost Are Ranked As The Best VPS Hosting Suppliers 2Health News:Kind LED K5 Series XL1000 Grow Lights Sell Out in Only 2 Days 2Health News:Emassagechair.com is Celebrating Self-Improvement Month by Giving Away a Foot Massager 2Health News:Emassagechair.com is Celebrating Self-Improvement Month by Giving Away a Foot Massager 3
... Cell phones used by patients and their visitors were twice ... healthcare workers (HCW), according to a study published in the ... , the official publication of APIC - the Association for ... of researchers from the Department of Medical Microbiology at Inonu ...
... 70 different types of dementia, but these findings are shocking. ... the study", say researchers Elisabet Englund and Hans Brunnstrm at ... majority from the cities of Lund and Malm. All of ... the period 1996-2006 and been diagnosed with some form of ...
... Venous thromboembolism (VTE) is the third most common type ... Researchers at the Centre for Primary Health Care Research ... for venous thromboembolism in the entire Swedish population by ... with VTE compared with the children of parents who ...
... Ill. Functional magnetic resonance imaging (fMRI) may provide ... researchers at Columbia University in New York City, who ... children. Results of their study appear online and in ... is a spectrum disorder characterized by repetitive behaviors and ...
... -- Attacks by North American black bears on humans are ... population of the United States and Canada increases, new research ... of Wildlife Management , also dispels the myth that the ... protect. Researchers reveal that lone male black bears hunting people ...
... with asthma get the flu, they often land in the ... found a previously unknown biological pathway explaining why influenza induces ... 29 by the journal Nature Immunology , reveal that ... natural helper cells presenting a completely new set of ...
Cached Medicine News:Health News:Study finds dangerous bacteria on cell phones of hospital patients 2Health News:Difficulties in diagnosing dementia type 2Health News:New research may lead to improved diagnosis of autism 2Health News:Fatal Black Bear Attacks Rare But Rising 2Health News:Why does flu trigger asthma? 2
(Date:9/23/2014)... 2014  Savant HWP, Inc., a privately held ... human safety testing of 18-MC, an experimental treatment ... of 18-MC, administered as part of a double-blind, ... American partner, was well tolerated by healthy volunteers ... develop 18-MC as a treatment for many forms ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... additions to its Scientific Advisory Board.  The new members ... Davies , PhD. Dr. Acker is a ...
(Date:9/22/2014)... September 23, 2014 , ... authorities, increasing rigor for trial master file (TMF) accessibility ... largest TMF survey to date reveals an increase in ... provide auditors with remote access to their electronic trial ... surveyed in the Veeva 2014 Paperless TMF ...
Breaking Medicine Technology:Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4
... Va., Oct. 8 Mirixa Corporation, the leader ... hiring of Cheryl Hoffer as Vice President, Pharmacy ... Pharmacy Account Management team, supporting independent and chain ... The Pharmacy Account Management team also helps expand ...
... LAKE FOREST, Ill., Oct. 8 Hospira, Inc. (NYSE: ... pharmaceuticals, today signed a Business Cooperation Agreement with South ... outlines the business terms of a future distribution agreement ... Canada for eight biogeneric products that are currently under ...
Cached Medicine Technology:Mirixa Corporation Announces Key Pharmacy Network Hire 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 3
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
... Sheet. Medpor Sheets are commonly used ... craniofacial applications. The thinner 0.4 mm ... surgeon with greater flexibility and to ... insertion into the orbit. It is ...
... precise punching of the donor corneal ... use with disposable trephine blades. Unique ... centration of the donor tissue. Recessed ... held centrally under the trephine blade. ...
... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...
Medicine Products: